Literature DB >> 16696017

Amplification and overexpression of the cyclin D1 gene in head and neck squamous cell carcinoma.

X Wang1, Z P Pavelic, Y Q Li, L Wang, L Gleich, K Radack, J L Gluckman, P J Stambrook.   

Abstract

Aims-To determine cyclin D1 gene amplification and expression levels in head and neck squamous cell carcinoma (HNSCC) patients.Methods-Total RNA and genomic DNA were isolated from 40 samples of HNSCC tissue and matched normal tissue and were hybridised with a cyclin D1 cDNA probe. Northern and Southern analyses were used to detect mRNA overexpression and cyclin D1 gene amplification, respectively.Results-15 of the 40 HNSCC samples examined (38%) showed cyclin D1 gene amplification. Of these 15 samples, all 13 from which RNA was available showed increased cyclin D1 expression.Conclusions-HNSCC patients with both amplification and overexpression of the cyclin D1 gene are at greater risk than patients who showed no cyclin D1 gene amplification; amplification and over-expression of the cyclin D1 gene may play an important role in the progression of HNSCC and in clinical outcome.

Entities:  

Year:  1995        PMID: 16696017      PMCID: PMC407980          DOI: 10.1136/mp.48.5.m256

Source DB:  PubMed          Journal:  Clin Mol Pathol        ISSN: 1355-2910


  30 in total

1.  Amplification of the int-2 gene in human head and neck squamous cell carcinomas.

Authors:  K D Somers; S L Cartwright; G L Schechter
Journal:  Oncogene       Date:  1990-06       Impact factor: 9.867

2.  Amplification at chromosome 11q13 in transitional cell tumours of the bladder.

Authors:  A J Proctor; L M Coombs; J P Cairns; M A Knowles
Journal:  Oncogene       Date:  1991-05       Impact factor: 9.867

3.  Overexpression of cyclin D1 correlates with recurrence in a group of forty-seven operable squamous cell carcinomas of the head and neck.

Authors:  R Michalides; N van Veelen; A Hart; B Loftus; E Wientjens; A Balm
Journal:  Cancer Res       Date:  1995-03-01       Impact factor: 12.701

4.  Frequent amplification of the bcl-1 locus in head and neck squamous cell carcinomas.

Authors:  J R Berenson; J Yang; R A Mickel
Journal:  Oncogene       Date:  1989-09       Impact factor: 9.867

5.  Frequent amplification of the bcl-1 locus in poorly differentiated squamous cell carcinoma of the lung. The Lung Cancer Study Group.

Authors:  J R Berenson; H Koga; J Yang; J Pearl; E C Holmes; R Figlin
Journal:  Oncogene       Date:  1990-09       Impact factor: 9.867

6.  Analysis of gene amplification in head-and-neck squamous-cell carcinoma.

Authors:  J H Leonard; J H Kearsley; G Chenevix-Trench; N K Hayward
Journal:  Int J Cancer       Date:  1991-06-19       Impact factor: 7.396

7.  Amplification and expression of the human cyclin D gene in esophageal cancer.

Authors:  W Jiang; S M Kahn; N Tomita; Y J Zhang; S H Lu; I B Weinstein
Journal:  Cancer Res       Date:  1992-05-15       Impact factor: 12.701

8.  Amplification of genes within the chromosome 11q13 region is indicative of poor prognosis in patients with operable breast cancer.

Authors:  E Schuuring; E Verhoeven; H van Tinteren; J L Peterse; B Nunnink; F B Thunnissen; P Devilee; C J Cornelisse; M J van de Vijver; W J Mooi
Journal:  Cancer Res       Date:  1992-10-01       Impact factor: 12.701

9.  Amplification of human int-2 in breast cancers and squamous carcinomas.

Authors:  D J Zhou; G Casey; M J Cline
Journal:  Oncogene       Date:  1988-03       Impact factor: 9.867

10.  A novel cyclin encoded by a bcl1-linked candidate oncogene.

Authors:  T Motokura; T Bloom; H G Kim; H Jüppner; J V Ruderman; H M Kronenberg; A Arnold
Journal:  Nature       Date:  1991-04-11       Impact factor: 49.962

View more
  5 in total

1.  High SEPT9_v1 Expression Is Associated with Poor Clinical Outcomes in Head and Neck Squamous Cell Carcinoma.

Authors:  Laura Stanbery; Nisha J D'Silva; Julia S Lee; Carol R Bradford; Thomas E Carey; Mark E Prince; Gregory T Wolf; Francis P Worden; Kitrina G Cordell; Elizabeth M Petty
Journal:  Transl Oncol       Date:  2010-08-01       Impact factor: 4.243

2.  Deletion and methylation of the tumour suppressor gene p16/CDKN2 in primary head and neck squamous cell carcinoma.

Authors:  M V González; M F Pello; C López-Larrea; C Suárez; M J Menéndez; E Coto
Journal:  J Clin Pathol       Date:  1997-06       Impact factor: 3.411

3.  Overexpression of glutathione S-transferase pi messenger RNA and its relationship to gene amplification in head and neck squamous cell carcinoma.

Authors:  Z P Pavelic; X Wang; Y Li; L Gleich; J L Gluckman; P J Stambrook
Journal:  Eur Arch Otorhinolaryngol       Date:  1997       Impact factor: 2.503

4.  Long non-coding RNA LINC00460 promotes head and neck squamous cell carcinoma cell progression by sponging miR-612 to up-regulate AKT2.

Authors:  Xiaoxing Xie; Gaoyun Xiong; Qingliang Wang; Yanping Ge; Xiaoying Cui
Journal:  Am J Transl Res       Date:  2019-10-15       Impact factor: 4.060

5.  Genetic analysis of single disseminated tumor cells in the lymph nodes and bone marrow of patients with head and neck squamous cell carcinoma.

Authors:  Karl Christoph Sproll; Lara K Schorn; Benedikt Reising; Sarah Schumacher; Julian Lommen; Norbert R Kübler; Wolfram Trudo Knoefel; Manfred Beier; Rui P Neves; Bianca Behrens; Kai Horny; Nikolas H Stoecklein
Journal:  Mol Oncol       Date:  2021-10-31       Impact factor: 6.603

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.